Q4 2025 Earnings Call Transcript July 31, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.55, expectations were $2.49. Operator: Hello, and welcome to the Q4 Fiscal Year 2025 ResMed ...

Lung function tests play a major role in the diagnosis and treatment of respiratory diseases such as asthma, chronic ...

Coughing, wheezing and shortness of breath are all familiar respiratory complaints a lot of people think of as signs of ...